Tuberculosis, Multidrug-Resistant
Showing 1 - 25 of 28
Strengthening Evidence on Optimal Multidrug-resistant
Recruiting
- Tuberculosis, Multidrug-Resistant
- HIV
- Bdq, Lzd, Lfx, Dlm, Cfz (9-12 months)
- +2 more
-
Almaty, Kazakhstan
- +2 more
May 12, 2023
Clinical Evaluation of tNGS for Diagnosis of DR-TB
Active, not recruiting
- Tuberculosis, Multidrug-Resistant
- targeted Next Generation Sequencing (tNGS)
-
Tbilisi, Georgia
- +2 more
Jan 23, 2023
Tuberculosis, Multidrug-Resistant, Tuberculosis, Tuberculosis, Pulmonary Trial in Worldwide (Linezolid 600 mg, Linezolid 1200 mg
Recruiting
- Tuberculosis, Multidrug-Resistant
- +2 more
- Linezolid 600 mg
- +7 more
-
Gaborone, South-East District, Botswana
- +16 more
Dec 13, 2022
Tuberculosis, Thoracic Surgery, Tuberculosis, Pulmonary Trial in Tbilisi (therapeutical surgery for TB)
Active, not recruiting
- Tuberculosis
- +3 more
- therapeutical surgery for TB
-
Tbilisi, GeorgiaNational Center for Tuberculosis and Lung Diseases
Sep 9, 2022
Tuberculosis, Multidrug-Resistant Trial in Dasmariñas, Hanoi (Delamanid, Levofloxacin, Bedaquiline)
Recruiting
- Tuberculosis, Multidrug-Resistant
- Delamanid
- +4 more
-
Dasmariñas, Philippines
- +1 more
Jun 21, 2022
Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Bedaquiline,
Completed
- Tuberculosis, Pulmonary
- +4 more
- Pretomanid
- +5 more
-
Rio de Janeiro, Brazil
- +25 more
Jun 23, 2022
Expand New Drugs for TB [endTB]
Completed
- Tuberculosis, Multidrug-Resistant
- This is a non-intervention observational study
-
Abovyan, Armenia
- +15 more
Jun 9, 2022
Bioneer Accupower Q-RFIA PCR Kit Clinical Evaluation
Recruiting
- Tuberculosis, Multidrug-Resistant
-
Nairobi, Kenya
- +2 more
Mar 16, 2022
Tuberculosis, Multidrug-Resistant, Tuberculosis, Pulmonary Tuberculoses Trial in Worldwide (Bedaquiline 100 MG, Delamanid 50 MG
Recruiting
- Tuberculosis, Multidrug-Resistant
- +5 more
- Bedaquiline 100 MG
- +4 more
-
Pune, India
- +9 more
Mar 2, 2022
Tuberculosis, Multidrug-Resistant, Infection, Bacterial, Pulmonary Tuberculoses Trial in Worldwide (Bedaquiline, Delamanid,
Active, not recruiting
- Tuberculosis, Multidrug-Resistant
- +2 more
- Bedaquiline
- +7 more
-
Tbilisi, Georgia
- +11 more
Feb 14, 2022
Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Worldwide (Pretomanid, Linezolid,
Active, not recruiting
- Tuberculosis, Pulmonary
- +5 more
- Pretomanid
- +3 more
-
Tbilisi, Georgia
- +10 more
Jan 26, 2022
Tuberculosis, Multidrug-Resistant Trial in Worldwide (Delamanid, OBR)
Completed
- Tuberculosis, Multidrug-Resistant
-
Beijing, China
- +7 more
Sep 30, 2021
Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Tuberculosis, MDR Trial in Johannesburg, Port Elizabeth, Rustenburg
Recruiting
- Tuberculosis, Pulmonary
- +4 more
- Pretomanid
- +3 more
-
Johannesburg, South Africa
- +2 more
Oct 4, 2021
Tuberculosis, Multidrug-Resistant Trial in Cape Town (Targeted sequencing using the GenoScreen Deeplex assay)
Not yet recruiting
- Tuberculosis, Multidrug-Resistant
- Targeted sequencing using the GenoScreen Deeplex assay
-
Cape Town, Western Cape, South AfricaUniversity of Cape Town
Sep 28, 2021
Hotspots, Households and Hospitals: Enhanced Drug-resistant
Not yet recruiting
- Tuberculosis, Multidrug-Resistant
- (no location specified)
Aug 19, 2021
Xpert MTB/XDR Clinical Evaluation Trial
Completed
- Tuberculosis, Pulmonary
- Tuberculosis, Multidrug-Resistant
- Cepheid Gene Xpert MTB/XDR
-
Chisinau, Moldova, Republic ofInstitute of Pthisiopenumology
May 17, 2021
Tuberculosis, Multidrug-Resistant, Extensively Drug-Resistant Tuberculosis, Tuberculosis, Pulmonary Trial in Belarus, South
Active, not recruiting
- Tuberculosis, Multidrug-Resistant
- +2 more
- Bedaquiline
- +5 more
-
Minsk, Belarus
- +6 more
May 12, 2021
Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant, Bacterial Infections Trial in Worldwide (Individualised treatment
Recruiting
- Tuberculosis, Pulmonary
- +3 more
- Individualised treatment duration based on RNA transcriptomic model
-
Borstel, Schleswig-Holstein, Germany
- +4 more
Apr 7, 2021
Tuberculosis, Multidrug-Resistant Trial in Kiyose, Sakai (TMC207 (bedaquiline), Background Regimen (BR))
Completed
- Tuberculosis, Multidrug-Resistant
- TMC207 (bedaquiline)
- Background Regimen (BR)
-
Kiyose, Japan
- +1 more
Oct 30, 2019
Fluoroquinolones in Multi-Drug Resistant Tuberculosis Patients
Unknown status
- Tuberculosis, Multidrug-Resistant
- Centralized Therapeutic Drug Monitoring
-
Brisbane, Australia
- +12 more
Oct 8, 2019
Biomarkers for Therapy Response in Drug-resistant Tuberculosis
Unknown status
- Tuberculosis, Multidrug-resistant
- no intervention
-
Borstel, Schleswig-Holstein, GermanyResearch Center Borstel
Sep 20, 2019
Nosocomial Transmission of MDR-TB in Bucharest, Romania
Unknown status
- Tuberculosis, Multidrug-resistant
- Routine management practices applied
-
Bucharest, RomaniaMarius Nasta Pulmonology Institute
Sep 20, 2019
Tuberculosis, Multidrug-Resistant Trial in Seoul (Linezolid, Delamanid, Levofloxacin)
Unknown status
- Tuberculosis, Multidrug-Resistant
- Linezolid
- +4 more
-
Seoul, Korea, Republic ofDivision of Pulmonology and Critical Care Medicine, Department o
Jan 31, 2019
Tuberculosis in China
Completed
- Tuberculosis
- +2 more
-
Zhengzhou, ChinaHenan Provincial Chest Hospital
Apr 4, 2018